⚠️ JAN 12 – FEB 6 CYBERATTACK: ALL ORDERS REFUNDED • DO NOT PURCHASE UNTIL FURTHER NOTICE • CONTACT support@anubis.estate FOR REFUND STATUS
Post-market surveillanceMitochondrial Peptide

Compound 61725

Formula Pending

Molecular Mass
N/A
CAS Registry
AUTO-061725
Risk Class
LOW
Last Audit
Jul 1, 2108

Research Abstract

Mitochondrial Peptide candidate engineered for metabolic regulation initiatives with automated dossier coverage.

Compound 61725 is a mitochondrial peptide asset inside mitochondrial peptide innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.

The dossier currently sits in post-market surveillance with a low risk rating, meaning it is cleared for baseline monitoring protocols.

Supply records cite CAS AUTO-061725 with updates logged 2108-07-01.

Acquisition Protocol

Authorized research personnel may request deployment of this compound for laboratory analysis.

Primary Vectors

Metabolic regulationCardiometabolic recovery

Nomenclature

CX-61725Mitochondrial Peptide Program 61725

Reference Material

  1. [1] Anubis Compound Registry • CAS AUTO-061725
  2. [2] Operations Pulse • Mitochondrial Peptide innovation track
  3. [3] Risk Governance Ledger • LOW clearance for COMPOUND-61725